|
2.6 Etiologie - Environnement
|
|
|
Monsanto says its pesticides are safe. Now, a court wants to see the proof [The Guardian]
|
|
|
|
|
|
The
court has dubbed the 5-9 March events as “science week” because the
only evidence to be presented will come from experts in cancer science,
including epidemiologists, toxicologists and others called to analyze
relevant research. There will be no crying cancer victims to tug on
heart strings; just opposing sides presenting science to a judge who
will decide if the lawsuits can move forward.
|
|
|
|
|
|
|
4. Dépistage, diagnostic et pronostic
|
|
|
New method could predict leukemia relapse at diagnosis [Stanford Medicine]
|
|
|
|
|
|
Blood
cells develop in a long, multi-stage process; the team found that if a
patient's cancer arose from one of two very specific stages in blood
cell development, that individual was likely to relapse after the
initial rounds of chemo. The prediction method was both faster and more
accurate than existing methods for predicting leukemia relapse.
|
|
|
|
|
|
|
4.10 Dép., diag. & prono. - FDA, EMA, NICE,...
|
|
|
FDA Finalizes ICH’s Genomic Sampling Guidance [RAPS]
|
|
|
|
|
|
The
guidance also came into effect for device and drug makers in the EU
this week, according to a notice from the European Medicines Agency.
Japan’s Pharmaceuticals and Medical Device Agency adopted it on 18
January.
|
|
|
|
|
|
|
4.12 Biopsies liquides
|
|
|
|
5.12.10 Immunothérapies - Fusions et acquisitions
|
|
|
|
5.12.2 Immunothérapies - CAR-T
|
|
|
|
5.12.5 Immunothérapies - Pharma
|
|
|
|
5.2.1 Pharma - Partenariats
|
|
|
|
5.2.2 Pharma - Fusions & Acquisitions
|
|
|
|
|
|
5.3 Traitements - FDA, EMA, NICE...
|
|
|
|
5.4 Traitements - Economie
|
|
|
The Price They Pay [NY Times]
|
|
|
|
|
|
There’s
no dispute that Gleevec is a breakthrough cancer drug. It is also a
very expensive one whose cost has increased sharply over the years.
|
|
|
|
|
|
|
5.6 ESMO
|
|
|
|
|
|
6.1 Observation
|
|
|
|
6.6 Publications
|
|
|
False investigators and coercive citation are widespread in academic research [LSE Impact Blog]
|
|
|
|
|
|
In
a recent study we found widespread abuses in academic citation and
authorship. Two activities seem particularly egregious. The first,
labelled false investigators, refers to adding extra investigators to
grant proposals even though they are not expected to contribute to the
research. The second is coercive citation, referring to editors who
coerce authors to add citations to manuscripts even though those
citations were not part of the scholars’ reference material.
|
|
|
|
|
|
|
|
6.7 DMP, Big Data & applis
|
|
|
Uncovering trends in the future of real world data [Pharmafile]
|
|
|
|
|
|
A
new report has canvassed the intentions of industry players in the use
of real world data and evidence over the coming years. Matt Fellows
speaks to the study’s lead author and executives at Amgen and
AstraZeneca to interpret how they expect the space to develop.
|
|
|
|
|
|
|
6.7.3 DMP
|
|
|